AzTrials
AzTrials

FrailtyNCT06185270

Effects of Preoperative Frailty on Postoperative Recovery

An observational study of Frailty, run by Seoul National University Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to evaluate frailty using Short Physical Performance Battery (SPPB) before surgery and find out how frailty affects short-term postoperative recovery after surgery using Quality of Recovery-15 (QOR-15) questionnaire in patients undergoing minimally invasive distal gastrectomy for early gastric cancer. Read more about this study

Who is it for?
Ages 70 years and older
Conditions the study is for
Frailty
What is being tested?
SPPB
How many people
139 participants
Where
No sites listed yet
Study dates
26 Dec 2023to 25 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Patients over 70 years of age, undergoing minimal invasive (laparoscopic, robot-assisted) distal gastrectomy for early gastric cancer, who can assess short-term postoperative recovery

Who may be able to join

  • Patients over 70 years of age, undergoing minimal invasive (laparoscopic, robot-assisted) distal gastrectomy for early gastric cancer, who can assess short-term postoperative recovery

Who cannot join

  • Patients who have a difficulty in communication
  • Patients who have a major medical or mental disease that can affect treatment outcome
  • Patients unsuitable for this clinical trail on the opinion of researcher

About this study

Official title: Effects of Preoperative Frailty Assessed by Short Physical Performance Battery (SPPB) on Short-term Postoperative Recovery Among Gastric Cancer Patients Undergoing Minimally Invasive Distal Gastrectomy

This study aims to evaluate frailty using Short Physical Performance Battery (SPPB) before surgery and find out how frailty affects short-term postoperative recovery after surgery using Quality of Recovery-15 (QOR-15) questionnaire in patients undergoing minimally invasive distal gastrectomy for early gastric cancer.

Read the detailed description

As the elderly population increases, the evaluation and management of preoperative frailty is becoming important. In patients with frailty, exposure to external stress, such as surgery, can reduce physical function, increase postoperative complication, and raise the risk of death. This study aims to evaluate frailty using an automated device performing SPPB (Andantefit) and find out how frailty affects postoperative recovery.

Conditions
Frailty
Being tested
SPPB
Medical subject headings
Frailty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SPPBDiagnostic test

    Short Physical Performance Battery using the automated device (Andantefit)

Study groups in NCT06185270
Study groupRoleWhat they receive
Patients undergoing minimally invasive distal gastrectomy for early gastric cancerNot described
Receives: Diagnostic Test: SPPB

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Poor postoperative outcome (the Korean version of Quality of Recovery-15 [QoR-15K] < 122)

    The minimum and maximum values of QoR-15K are 0 and 150, respectively. Higher scores mean better outcomes.

    Measured: on postoperative day 3

Secondary outcomes (2)
  1. Poor postoperative outcome (the Korean version of Quality of Recovery-15 [QoR-15K] < 122)

    The minimum and maximum values of QoR-15K are 0 and 150, respectively. Higher scores mean better outcomes.

    Measured: on postoperative day 1

  2. Poor postoperative outcome (the Korean version of Quality of Recovery-15 [QoR-15K] < 122)

    The minimum and maximum values of QoR-15K are 0 and 150, respectively. Higher scores mean better outcomes.

    Measured: on postoperative day 2

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Dec 2023
  2. Study start26 Dec 2023 (estimated)
  3. Primary completion25 Dec 2024 (estimated)
  4. Study completion25 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
139 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06185270
Sponsor's protocol ID
2308-179-1462
Status last verified
Nov 2023
First submitted
5 Nov 2023
Last updated
29 Dec 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Frailty, run by Seoul National University Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Poor postoperative outcome (the Korean version of Quality of Recovery-15 [QoR-15K] < 122) (time frame: on postoperative day 3). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in